Abstract

Bosutinib Vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia (CML) in the BFORE Trial: 18 Month Follow-up

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs
Andreas Hochhaus ...
Blood | VOL. 136
Andreas Hochhaus, et. al.Andreas Hochhaus ...
19 Nov 2020
Bosutinib (BOS) Versus Imatinib for Newly Diagnosed Chronic Phase (CP) Chronic Myeloid Leukemia (CML): Final 5-Year Results from the Bfore Trial
Tim H Brümmendorf ... Michael W Deininger
Blood | VOL. 136
Tim H Brümmendorf, et. al.Tim H Brümmendorf ... Michael W Deininger
05 Nov 2020
Asciminib, a First-in-Class STAMP Inhibitor, Provides Durable Molecular Response in Patients (pts) with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: Primary Efficacy and Safety Results from a Phase 1 Trial
...
Blood | VOL. 136
, et. al. ...
05 Nov 2020
Molecular Responses with Ponatinib in Patients with Philadelphia Chromosome Positive (Ph+) Leukemia: Results From the PACE Trial
Andreas Hochhaus ...
Blood | VOL. 120
Andreas Hochhaus, et. al.Andreas Hochhaus ...
16 Nov 2012
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Momelotinib for the treatment of myelofibrosis.
Prithviraj Bose
Blood | VOL. -
Prithviraj BosePrithviraj Bose
03 Jul 2024
Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.
Samuel C.C Chiang ... Yenan T Bryceson
Blood | VOL. -
Samuel C.C Chiang, et. al.Samuel C.C Chiang ... Yenan T Bryceson
03 Jul 2024
Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications.
Elsa Bernard ... Elli Papaemmanuil
Blood | VOL. -
Elsa Bernard, et. al.Elsa Bernard ... Elli Papaemmanuil
03 Jul 2024
Eltrombopag plus diacerein vs. eltrombopag in patients with ITP: a multicenter, randomized, open-label, phase 2 trial.
Lu Sun ... Yu Hou
Blood | VOL. -
Lu Sun, et. al.Lu Sun ... Yu Hou
03 Jul 2024
View more papers